Masood Hassan
@mhassanaimc
Assistant Professor @UMMC_pathology. Surgical/Breast Pathology fellowship @Wusm_pathology T/RT ≠ medical advice. Interested in #Breastpath #GYNpath #GUpath
This gland lacks a myoepithelial layer—should we call it microinvasive cancer? No. Why? Because we assess in 2D, but glands are 3D. The plane of section may miss myoepithelial cells. Loss of p63 doesn’t always mean cancer. See last slide of independent p63 #breastpath




I’m definitely not a Dermatopathologist — just your friendly neighborhood breastpath pretending to know things — but I wanted to get your eyes on this one. What’s the name of this cute eyelid lesion on 85-year-old female? Asking just for curosity.



50/F with palpable breast mass with p63 loss (no brown stain) and Keratin (red) is shown. You call cancer: Patient gets mastectomy. You call benign nothing happens. What would you call? #breastpath




🎉 Congratulations to our graduating residents Navdeep, Selcuk, and Nazar! Your hard work has paid off, and we can’t wait to see the amazing things you’ll achieve. Best of luck on your next adventures!




Thank you, @CSTaylor, for an exceptional lecture on effective presentation skills! Your significant contributions to the education of our residents are greatly appreciated.😊😊😊

Utility of E-cadherin. 1) How would you interpret this E-cadherin staining pattern? 2) Will you call invasive lobular carcinoma? #breastpath




Invasive breast carcinoma involving the fibroadenoma with extensive lymphovascular space invasion #breastpath


Utility of E-cadherin. Is morphology good enough for Invasive lobular carcinoma? #breastpath


Utility of E-cadherin, Is morphology good enough for Invasive ductal carcinoma? #breastpath


